Loading...
XNYS
NVST
Market cap3.35bUSD
Jul 17, Last price  
19.75USD
1D
0.15%
1Q
30.11%
IPO
-29.46%
Name

Envista Holdings Corp

Chart & Performance

D1W1MN
No data to show
P/E
P/S
1.33
EPS
Div Yield, %
Shrs. gr., 5y
4.77%
Rev. gr., 5y
-1.82%
Revenues
2.51b
-2.18%
2,785,400,0002,810,900,0002,844,500,0002,751,600,0002,282,000,0002,508,900,0002,569,100,0002,566,500,0002,510,600,000
Net income
-1.12b
L+1,016.37%
272,000,000301,100,000230,700,000217,600,00033,300,000263,500,000243,100,000-100,200,000-1,118,600,000
CFO
337m
+22.05%
417,000,000359,100,000400,100,000397,500,000283,900,000391,400,000182,700,000275,700,000336,500,000
Earnings
Aug 05, 2025

Profile

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
IPO date
Sep 18, 2019
Employees
16,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
2,510,600
-2.18%
2,566,500
-0.10%
2,569,100
2.40%
Cost of revenue
1,237,000
1,209,800
1,194,400
Unusual Expense (Income)
NOPBT
1,273,600
1,356,700
1,374,700
NOPBT Margin
50.73%
52.86%
53.51%
Operating Taxes
33,900
45,300
45,900
Tax Rate
2.66%
3.34%
3.34%
NOPAT
1,239,700
1,311,400
1,328,800
Net income
(1,118,600)
1,016.37%
(100,200)
-141.22%
243,100
-7.74%
Dividends
Dividend yield
Proceeds from repurchase of equity
(7,900)
12,700
BB yield
0.20%
-0.21%
Debt
Debt current
150,500
175,900
537,000
Long-term debt
1,550,600
1,648,200
1,140,500
Deferred revenue
8,400
8,600
Other long-term liabilities
139,800
134,000
7,100
Net debt
632,000
884,100
1,231,100
Cash flow
Cash from operating activities
336,500
275,700
182,700
CAPEX
(33,800)
(58,200)
(75,700)
Cash from investing activities
(54,600)
(62,400)
(657,300)
Cash from financing activities
(103,700)
118,900
12,500
FCF
1,444,000
1,181,400
1,177,600
Balance
Cash
1,069,100
940,000
606,900
Long term investments
(160,500)
Excess cash
943,570
811,675
317,945
Stockholders' equity
(856,800)
415,700
507,900
Invested Capital
5,479,100
5,584,500
5,391,655
ROIC
22.41%
23.90%
24.50%
ROCE
27.55%
22.61%
23.52%
EV
Common stock shares outstanding
172,200
166,900
177,600
Price
19.29
-19.83%
24.06
-28.54%
33.67
-25.28%
Market cap
3,321,738
-17.28%
4,015,614
-32.85%
5,979,792
-25.28%
EV
3,953,738
4,899,714
7,210,892
EBITDA
1,314,400
1,519,300
1,536,800
EV/EBITDA
3.01
3.22
4.69
Interest
46,400
63,400
38,400
Interest/NOPBT
3.64%
4.67%
2.79%